SynthesisCancer control : journal of the Moffitt Cancer Center
Ensemble RBE Modeling in Proton Therapy: A Meta-Synthesis Framework for Dose Assessment in the Brainstem and Spinal Cord.
Synthesis in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IntroductionProton therapy minimizes damage to healthy tissues while effectively targeting tumors. However, uncertainties in relative biological effectiveness (RBE) calculations remain a challenge, particularly for critical organs at risk (OARs), such as the brainstem and spinal cord. This study introduces ensemble RBE models (eRBE-B and eRBE-SC) developed through a meta-synthesis (MS) approach to improve dose accuracy and stability in proton radiotherapy.Materials and MethodsA systematic literature review following PRISMA guidelines identified studies utilizing variable RBE models. The MS approach aggregates data on model usage patterns and study quality due to the lack of direct RBE measurements. Three primary models (Carabe, Wedenberg, and McNamara) were weighted on the basis of study quality and case counts to construct ensemble RBE models. Dose calculations and analysis were performed via RayStation 8B, MCsquare, and 3D Slicer.ResultsCompared with the Carabe model, the eRBE-B model resulted in reduced dose underestimation, with mean dose (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.